Profiling Novel Quinuclidine-Based Derivatives as Potential Anticholinesterase Drugs: Enzyme Inhibition and Effects on Cell Viability
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms25010155 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Suzana Žunec und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Toxicology, Institute for Medical Research and Occupational Health, Ksaverska c. 2, 10000 Zagreb, Croatia. Hauptthemen laut MEDLINE: Cholinesterase Inhibitors, Butyrylcholinesterase. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Croatian Science Foundation, Research and Education Centre of Environmental Health and Radiation Protection–Reconstruction and Expansion of the Institute for Medical Research and Occupatio….
Abstract (Originalsprache)
The cholinergic system, relying on the neurotransmitter acetylcholine (ACh), plays a significant role in muscle contraction, cognition, and autonomic nervous system regulation. The enzymes acetylcholinesterase, AChE, and butyrylcholinesterase, BChE, responsible for hydrolyzing ACh, can fine-tune the cholinergic system’s activity and are, therefore, excellent pharmacological targets to address a range of medical conditions. We designed, synthesized, and profiled 14 N-alkyl quaternary quinuclidines as inhibitors of human AChE and BChE and analyzed their impact on cell viability to assess their safety in the context of application as potential therapeutics. Our results showed that all of the 14 tested quinuclidines inhibited both AChE and BChE in the micromolar range (Ki = 0.26 − 156.2 μM). The highest inhibition potency was observed for two bisquaternary derivatives, 7 (1,1′-(decano)bis(3-hydroxyquinuclidinium bromide)) and 14 (1,1′-(decano)bis(3-hydroxyiminoquinuclidinium bromide)). The cytotoxic effect within 7–200 μM was observed only for monoquaternary quinuclidine derivatives, especially those with the C12–C16 alkyl chain. Further analysis revealed a time-independent mechanism of action, significant LDH release, and a decrease in the cells’ mitochondrial membrane potential. Taking all results into consideration, we can confirm that a quinuclidine core presents a good scaffold for cholinesterase binding and that two bisquaternary quinuclidine derivatives could be considered as candidates worth further investigations as drugs acting in the cholinergic system. On the other hand, specific cell-related effects probably triggered by the free long alkyl chain in monoquaternary quinuclidine derivatives should not be neglected in future N-alkyl quaternary quinuclidine derivative structure refinements. Such an effect and their potential to interact with other specific targets, as indicated by a pharmacophore model, open up a new perspective for future investigations of these compounds’ scaffold in the treatment of specific conditions and diseases other than cholinergic system-linked disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Toxicology, Institute for Medical Research and Occupational Health, Ksaverska c. 2, 10000 Zagreb, Croatia.
- Armed Forces of the Republic of Croatia, Trg Kralja Petra Krešimira IV br. 1, 10000 Zagreb, Croatia.
- Faculty of Science, University of Zagreb, Horvatovac 102a, 10000 Zagreb, Croatia.
ORCID-Profile: Suzana Žunec, Antonio Zandona, Nikola Maraković, Ines Primožič, Maja Katalinić
Förderung
- Croatian Science Foundation
- Research and Education Centre of Environmental Health and Radiation Protection–Reconstruction and Expansion of the Institute for Medical Research and Occupatio…
Zitieren
APA
Žunec, S., Vadlja, D., Ramić, A., Zandona, A., Maraković, N., Brekalo, I., Primožič, I., & Katalinić, M. (2023). Profiling Novel Quinuclidine-Based Derivatives as Potential Anticholinesterase Drugs: Enzyme Inhibition and Effects on Cell Viability. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25010155
Vancouver
Žunec S, Vadlja D, Ramić A, Zandona A, Maraković N, Brekalo I, et al. Profiling Novel Quinuclidine-Based Derivatives as Potential Anticholinesterase Drugs: Enzyme Inhibition and Effects on Cell Viability. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms25010155
BibTeX
@article{unec2023,
author = {Žunec, Suzana and Vadlja, Donna and Ramić, Alma and Zandona, Antonio and Maraković, Nikola and Brekalo, Iva and Primožič, Ines and Katalinić, Maja},
title = {Profiling Novel Quinuclidine-Based Derivatives as Potential Anticholinesterase Drugs: Enzyme Inhibition and Effects on Cell Viability},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms25010155}
}
EUVIMED